Baron Fifth Avenue Growth Fund gained 6.6% in Q3 2026, beating its benchmarks on strong AI and software stock selection. Read ...
Asian equity markets traded mostly lower on Monday, weighed down by weaker U.S. stock futures, elevated Treasury yields, and ...
Pony.ai and Toyota launch fully driverless Gen-7 bZ4X robotaxi services in Guangzhou, targeting about 1,000 vehicles across ...
Analyst rates Kura Oncology a Sell: $5.85 fair value is below $7.43; about $72 million in quarterly burn could leave net cash ...
Johnson & Johnson is in talks to buy Ollin Biosciences for up to $3.4B, including $2.2B upfront and $1.2B in potential ...
Increases in the first half of November included Emerson’s 7.2% boost for its 70th year of growth; ADP, ConocoPhillips, ...
Sociedad Química y Minera de Chile is a Buy: the recent selloff offers a long-term lithium opportunity despite a rocky ...
Analyst rates Albertsons a Strong Buy, with shares that could offer 53.6%-336.8% upside if valued at peer multiples.
I maintain a "Buy" rating on DiaMedica Therapeutics, supported by DM199 catalysts across stroke, preeclampsia, and fetal ...
The bear case on IonQ: valuation still looks aggressive after a 60% fall from its 52-week high; stock-funded deals nearly ...
BlackRock Utilities Infrastructure & Power Opportunities Trust remains a Buy: its below-average price-to-NAV valuation and AI ...
Analyst rates Fortinet a Buy: 2026 guidance calls for 28% billings growth at midpoint and 13% service revenue growth, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results